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Huntington’s disease (HD) is a hereditary neurodegenerative disease caused by the
expansion of a polyglutamine stretch in the huntingtin (HTT) protein and characterized
by dysregulated calcium homeostasis. We investigated whether these disturbances are
correlated with changes in the mRNA level of the genes that encode proteins involved
in calcium homeostasis and signaling (i.e., the calciosome). Using custom-made TaqMan
low-density arrays containing probes for 96 genes, we quantified mRNA in the striatum in
YAC128 mice, a model of HD, and wildtype mice. HTT mutation caused the increased
expression of some components of the calcium signalosome, including calretinin,
presenilin 2, and calmyrin 1, and the increased expression of genes indirectly involved
in calcium homeostasis, such as huntingtin-associated protein 1 and calcyclin-binding
protein. To verify these findings in a different model, we used PC12 cells with an
inducible expression of mutated full-length HTT. Using single-cell imaging with Fura-2AM,
we found that store-operated Ca2+ entry but not endoplasmic reticulum (ER) store
content was changed as a result of the expression of mutant HTT. Statistically significant
downregulation of the Orai calcium channel subunit 2, calmodulin, and septin 4 was
detected in cells that expressed mutated HTT. Our data indicate that the dysregulation
of calcium homeostasis correlates with changes in the gene expression of members of
the calciosome. These changes, however, differed in the two models of HD used in this
study. Our results indicate that each HD model exhibits distinct features that may only
partially resemble the human disease.
Keywords: calcium signalosome, store-operated calcium entry, transgenic mice, TaqMan low-density arrays,
Huntington’s disease, huntingtin, huntingtin-associated protein 1, calcyclin-binding protein
INTRODUCTION
Cellular calcium transients control a vast array of cellular func-
tions, from short-term responses (e.g., contraction and secretion)
to the long-term regulation of cell growth and proliferation.
Cytosolic Ca2+ increases in response to activation of cell-surface
receptors, either directly after the activation of ionotropic glu-
tamate channels or indirectly after generation of the Ca2+-
mobilizing second messenger inositol 1,4,5-trisphosphate (IP3).
IP3 interacts with its receptors (IP3R1-3) on the membrane
of the endoplasmic reticulum (ER), the major store of Ca2+
in the cell. The opening of these IP3R Ca2+ channels releases
Ca2+ stored in the ER (Foskett et al., 2007). Increased cytosolic
Ca2+ can also cause Ca2+-induced release of Ca2+ from ryan-
odine receptors (RyR1-3) (Hamilton, 2005). The depletion of
ER Ca2+ stores results in activation of store-operated channels
(SOCs) at the plasma membrane, mediating store-operated cal-
cium entry (SOCE) from the extracellular space, followed by
the removal of cytosolic Ca2+ and replenishment of luminal
Ca2+ through sarcoplasmic/ER Ca2+-adenosine triphosphatases
(ATPases; SERCA1-3). Considering their electrophysiological and
molecular properties, two main types of SOCs can be described.
The first are the highly Ca2+-selective calcium release activated
calcium currents (ICRAC) mediated by the Orai family of pro-
teins, which carry highly Ca2+-selective ICRAC currents (Vig
et al., 2006). The second type of SOCs are non-selective Ca2+-
permeable TRPC (C-type transient receptor potential) channels
(Huang et al., 2006). The Ca2+ sensor’s stromal interaction
molecules 1 and 2 (STIM1 and STIM2) detect changes in Ca2+
concentration in the ER via an EF-hand Ca2+-binding domain,
in response to store depletion, they rearrange into punctate struc-
tures that are close to the plasma membrane. This activates
members of the Orai family (Orai1, Orai2, and Orai3) of Ca2+-
influx channels (Liou et al., 2005; Roos et al., 2005), resulting in
Ca2+ entry by ICRAC into the cell. STIM1 and Orai1 have also
been implicated with cell death and mitochondrial bioenergetics
(Henke et al., 2012, 2013). STIM1 and STIM2 are expressed in the
brain (Klejman et al., 2009; Skibinska-Kijek et al., 2009; Ng et al.,
2011; Steinbeck et al., 2011). The main function of STIM1 in neu-
rons appears to be the activation of SOCE (Gruszczynska-Biegala
et al., 2011). STIM1 directly suppresses the depolarization-
induced opening of the voltage-gated Ca2+ channel CaV1.2
by binding to the C-terminus of this channel, leading to the
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inhibition of gating and long-term internalization of the chan-
nel from the membrane (Park et al., 2010). The primary function
of STIM2 in neurons was suggested to be the regulation of the
resting level of Ca2+ in the ER and Ca2+ leakage (Gruszczynska-
Biegala et al., 2011; Gruszczynska-Biegala and Kuznicki, 2013).
To maintain the spatial and temporal properties of Ca2+ sig-
nals, neurons express numerous Ca2+-binding proteins that act
as Ca2+ buffers (Nikoletopoulou and Tavernarakis, 2012). In
the cytoplasm, parvalbumin (PV), calbindin D-28k (CALB1),
and calretinin (CALB2) (Billing-Marczak and Kuznicki, 1999)
act as Ca2+ buffers, whereas buffer proteins localized within the
lumen of the ER, including calsequestrin (CASQ) and calreticulin
(CALR) (Groenendyk et al., 2004; Michalak et al., 2009), allow
the store to accumulate the large amounts of Ca2+ necessary for
rapid cell signaling responses. These proteins involved in calcium
signaling and homeostasis represent a special toolkit referred to
as the Ca2+ signalosome (Berridge et al., 2003; Berridge, 2012).
Proper action of the Ca2+ signalosome is crucial for the
functioning of neuronal cells and during aging the Ca2+ sig-
naling machinery undergoes significant changes (Toescu and
Verkhratsky, 2007; Puzianowska-Kuznicka and Kuznicki, 2009).
Moreover, conclusive evidence indicates that neuronal Ca2+ sig-
naling is abnormal in many neurodegenerative disorders (Wojda
et al., 2008; Bezprozvanny, 2010). Notably, SOCE is dysregulated
in epilepsy (Steinbeck et al., 2011) and AD (Jaworska et al., 2013;
Ryazantseva et al., 2013). One of the neurodegenerative disorders
with disrupted Ca2+ homeostasis is Huntington’s disease (HD),
which is characterized clinically by chorea, dementia, and psychi-
atric symptoms. This genetic disorder is caused by the expansion
of a CAG trinucleotide repeat in exon 1 of the huntingtin gene
(HTT), which is translated into polyglutamine residues (polyQ)
in the huntingtin protein (HTT). Huntingtin is toxic to cells
when the number of CAG repeats exceeds 36, a point at which
HTT forms aggregates in the nuclei of neurons where it might
inhibit the function of various proteins, including key transcrip-
tional factors. This leads to transcriptional dysfunction and may
cause neuronal degeneration (Sugars and Rubinsztein, 2003; Li
and Li, 2004). HD is characterized at the molecular level by vari-
ous changes, including disturbances in calcium homeostasis and
signaling components, and these changes are considered to be
involved in various processes that lead to the neurodegeneration
observed in HD (Giacomello et al., 2011, 2013).
It is probable that destabilization of neuronal Ca2+ signaling
is one of the toxic functions of the mutant HTT. To test this
hypothesis, we used two models of HD: a cellular model and a
transgenic model overexpressing mutant HTT. Inducible PC12
cells overexpress an expanded HTT with 73 glutamines (Apostol
et al., 2003) and are useful for studying early changes in HD,
since they accumulate aggregates of mutant HTT upon treatment
with the steroid ponasterone A. Although others have used this
inducible PC12 model successfully to study HD pathogenesis, no
disturbances in the expression or function of the calcium sig-
nalosome have yet been described. However, it was shown that
the first 17 amino-acid residues of mutated HTT modulate its
sub-cellular localization, aggregation and effects on Ca2+ home-
ostasis in glutamate-challenged PC12 cells (Rockabrand et al.,
2007). Our HD animal model, YAC128 transgenic mice express
the full-length human HTT protein with 128 CAG repeats and
display an age-dependent loss of striatal neurons, similar to those
seen in human HD (Slow et al., 2003). YAC128 mice initially
exhibit hyperactivity, followed by the onset of motor deficits and
finally hypokinesis. Motor deficits in YAC128 mice are highly
correlated with striatal neuronal loss. There is compelling evi-
dence that supports Ca2+ dysfunction playing a central role in
the pathogenesis of HD. In medium spiny neurons (MSNs) from
YAC128 transgenic mice but not control mice, the activity of
SOCE was enhanced (Wu et al., 2011). Moreover, in a yeast two-
hybrid screen and YAC128 mice, an interaction between mutant
HTT and the 5C-terminus of IP3R1 was shown to be mediated
by huntingtin-associated protein-1A (Tang et al., 2003). Repeated
application of glutamate to MSNs in these mice elevated cytoso-
lic Ca2+ levels, resulting in apoptosis mediated by the activation
of Gq-coupled metabotropic glutamate receptors (Tang et al.,
2005). Similar results were shown in the HdH (Q111/Q111)
mouse model, in which agonist-induced Ca2+ release in neu-
rons from these mice was increased relative to (Q20/Q20) control
mice. Basal protein kinase B (PKB) activation was also higher
in HdH (Q111/Q111) neurons, and this process was dependent
on metabotropic glutamate receptor 5 (mGluR5) (Ribeiro et al.,
2010).
Although the effect of mutant HTT on SOCE was previously
studied in transgenic YAC128 mice (Wu et al., 2011), there is
no data concerning calcium signalosome alterations, which could
be considered to be involved in HD pathogenesis. Therefore, the
aim of our study was to investigate whether mutated HTT is
responsible for the changes in the expression of calciosome genes,
and if so, which of such changes might explain the alterations
observed in HD. Using custom-made TaqMan low-density arrays
and individual real-time quantitative polymerase chain reaction
(qRT-PCR), we studied changes in gene expression in two HD
models. Our arrays contained most of the genes involved in
calcium signaling and homeostasis, some genes responsible for
amyloid beta precursor protein (APP) processing and insulin sig-
naling, as well as a few genes that encode protein kinases or other
proteins connected with HD. We found increased expression of
few components of the calcium signalosome and genes indirectly
involved in calcium homeostasis in YAC128 brains. In PC12 cells
with induced expression of mutated full-length HTT, we detected
downregulation of the genes that encode some proteins involved
in the calcium signalosome. Our data indicate that the dysregula-
tion of calcium homeostasis correlates with changes in the gene
expression of members of the calciosome, but the two models
used in this study exhibit distinct changes in gene expression.
MATERIALS AND METHODS
ANIMALS
Female transgenic YAC128 mice that overexpressed human HTT
(128 Gln) and non-transgenic littermates that were applied as
controls aged between 3 and 6 months (Slow et al., 2003) were
used. The animals were kept under normal laboratory condi-
tions (12 h/12 h dark/light cycle; 50–60% relative humidity; 22◦C)
with food and water available ad libitum. Animal care was in
accordance with the European Communities Council Directive
(86/609/EEC). The experimental procedures were approved by
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the Local Commission for the Ethics of Animal Experimentation
No. 1 in Warsaw (approval no. 305/212).
EXAMINED BRAIN REGIONS
The striatum (head of the caudate nucleus), the primary (M1)
and secondary (M2) motor cortex, and the cerebellum were
identified macroscopically according to anatomical landmarks
(Paxinos and Franklin, 2004) in YAC128 and control mice brains.
These brain structures were isolated and kept in −80◦C until the
future experiments.
CELL CULTURES
PC12 cells with an inducible expression of full-length human
HTT containing 73 polyglutamine repeats translated from a ran-
dom codon with a TagRFP tag at the C-terminus were obtained
from the Coriell Institute for Medical Research. The PC12 cells
were grown to 90% confluence at 37◦C in a 5% CO2, 96%
relative humidity incubator in cell-culture plates (100 cm2; BD
Biosciences) treated with 10μg/μl poly-L-lysine (Sigma) in a cell
culture medium that contained 15% horse serum (HS; H1270,
Sigma), 2.5% fetal bovine serum (FBS; F7524, Sigma), and phenol
red-free Dulbecco’s Modified EagleMedium (DMEM; 41965-039,
Gibco) supplemented with 1% penicillin-streptomycin (P0781,
Sigma), 0.1mg/ml zeocin (R25001, Invitrogen), and 0.1mg/ml
geneticine (G8168, Sigma). The cells were passaged with a 1:5
dilution at least three times prior to the experiments. Each passage
consisted of 5min incubation with 2ml of trypsin replacement
(Sigma), the addition of 8ml of cell media to inactivate the
enzyme, and brief centrifugation (2min, 300 × g), followed by
media replacement. Cell suspensions were then added to the cell-
culture plates and pipetted into single cells. The cells grew to a
monolayer (> 50% confluence in 1–2 days), whereupon differen-
tiation into neuron-like cells was achieved by treatment with neu-
ral growth factor (NGF 2.5S, 100 ng/ml; 13257-019, Invitrogen)
for 48 h in low serum medium that contained DMEM, 1% HS,
and 0.25% FBS supplemented by antibiotics as above. To induce
the expression of human HTT, 2μM ponasterone A (P3490,
Sigma) was added to the differentiated cells for 48 h. As ponas-
terone A was dissolved in 100% ethanol, control cells were treated
with the same amount of 100% ethanol in parallel with the
ponasterone A-treated cells.
SINGLE-CELL Ca2+ MEASUREMENTS
Single-cell Ca2+ imaging was performed using the ratiometric
Ca2+ indicator dye Fura-2 acetoxymethyl ester (Fura-2 AM). The
cells (17,000 cells/well) were differentiated into neuron-like cells
in 96-well imaging plates (BD Bioscience) for 48 h and induced
to express human HTT 48 h before the experiment. The cells
were loaded with 5μMFura-2 AM (F1201, Molecular Probes) for
30min at 37◦C in Hank’s Balanced Salt Solution supplemented
with 2mMCaCl2 and then rinsed and left undisturbed for 30min
to allow for de-esterification. Calcium-free medium instead of
2mM CaCl2 contained 0.5mM ethylene glycol tetraacetic acid
(EGTA). The experiments were performed using a BD Pathway
855 High Content Imaging System (BD Biosciences). Images were
acquired at 340 and 380 nm excitation wavelengths, and the ratio
was calculated every 5 s for every cell.
RNA ISOLATION FROM BRAIN TISSUE AND PC12 CELLS
Brain samples were homogenized separately using a Potter-
Elvehjem homogenizer. RNA was extracted using the RNeasy
Lipid Tissue Mini kit with additional DNase treatment (Qiagen).
To isolate RNA from PC12 cells, homogenization was performed
using Qiashredders (Qiagen), and RNA was extracted using the
RNeasy Plus Mini kit (Qiagen). cDNA was synthesized by reverse
transcription (SuperScript III RnaseH, Invitrogen).
GENE EXPRESSION ANALYSIS
All gene expression analysis were performed using the 7900HT
system (Life Technologies). Gene profiling in the brain was per-
formed using custom-designed TaqMan low-density arrays (Life
Technologies), hereinafter referred to as RT-qPCR arrays. For
each array (384 assays), 1.6μg of cDNA was loaded. The obtained
data were analyzed using the relative quantification method and
2−CT formula (CT = CTtarget− CTGapdh, where CT denotes
the cycle threshold). The list of genes and their annotations
included in the RT-qPCR arrays is shown in Table 1. For RT-
qPCR arrays TaqMan chemistry (4369016, Life Technologies) was
used.
Single analyses of gene expression levels using cDNA prepa-
rations from PC12 cell cultures were performed in individual
real-time PCR reactions, hereinafter referred to as qRT-PCR. The
obtained data were quantified using the relative standard curve
method. For each gene, standard cDNAs were diluted and ampli-
fied along with sample cDNAs in the same PCR run. Standard
curves were generated using the 7900HT system software (Life
Technologies). The quantity of mRNA in each sample (R0) was
determined from the relative standard curve (using sample CT
values) and expressed in arbitrary units corresponding to the
dilution factors of the standard RNA preparation. The amplifi-
cation efficiency (E) of each PCR reaction was determined using
the equation of the standard curve:
CT = −1/log(E + 1) × log Ro + log R/log (E + 1)
E = 10−1/Slope − 1; slope = −1/log [E + 1].
Rat-specific primers were designed using Primer Blast (National
Center for Biotechnology Information), and their sequences
are shown in Table 2. For individual qRT-PCR in PC12 cells
SYBR Green chemistry (4385612, Life Technologies) was used.
The expression of the Tmem66, Cracr2a (Efcab4b), Ryr3, and
Atp2a1 genes was verified using FAM dye-labeled TaqMan
probes (Life Technologies) and TaqMan chemistry (4369016, Life
Technologies). The expression of Cracr2a (Efcab4b), Ryr3, and
Atp2a1was undetectable in PC12 cells using both hand-made and
custom-made primers.
IMMUNOBLOTTING
Cells were extracted in ice-cold RIPA buffer: 50mM Tris, pH
7.5, 150mM NaCl, 1% NP-40, 0.5% NaDOC, 0.1% sodium
dodecyl sulfate (SDS), and 1mM ethylenediaminetetraacetic acid
(EDTA) that contained mini complete protease inhibitor cock-
tail (Roche) and phosphatase inhibitors (Sigma). The lysed cells
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Table 1 | List of genes and their annotations included in the RT-qPCR
array.
Gene symbol Gene name Assay ID
Actb actin, beta Mm00607939_s1
Akt1 thymoma viral proto-oncogene 1 Mm01331626_m1
Akt2 thymoma viral proto-oncogene 2 Mm02026778_g1
Akt3 thymoma viral proto-oncogene 3 Mm00442194_m1
Aph1a anterior pharynx defective 1a
homolog (C. elegans)
Mm03647119_g1
Aph1b anteri or pharynx defective 1b
homolog (C. elegans)
Mm00781167_s1
Aph1c anterior pharynx defective 1c
homolog (C. elegans)
Mm00503295_m1
Apoe apolipoprotein E Mm01307193_g1
App amyloid beta precursor protein Mm01344172_m1
Atp2a1 ATPase, Ca2+ transporting,
cardiac muscle, fast twitch 1
Mm01275320_m1
Atp2a2 ATPase, Ca2+ transporting,
cardiac muscle, slow twitch 2
Mm01201431_m1
Atp2a3 ATPase, Ca2+ transporting,
ubiquitous
Mm00443897_m1
Atp2c1 ATPase, Ca2+ sequestering Mm00723486_m1
Bace1 beta-site APP cleaving enzyme 1 Mm00478664_m1
Cacna1a calcium channel,
voltage-dependent, P/Q type,
alpha 1A subunit
Mm00432190_m1
Cacna1b calcium channel,
voltage-dependent, N type, alpha
1B subunit
Mm01333678_m1
Cacna1c calcium channel,
voltage-dependent, L type, alpha
1C subunit
Mm01188822_m1
Cacna1d calcium channel,
voltage-dependent, L type, alpha
1D subunit
Mm01209919_m1
Cacna1e calcium channel,
voltage-dependent, R type, alpha
1E subunit
Mm00494444_m1
Cacna1g calcium channel,
voltage-dependent, T type, alpha
1G subunit
Mm00486572_m1
Cacna1h calcium channel,
voltage-dependent, T type, alpha
1H subunit
Mm00445382_m1
Cacna1i calcium channel,
voltage-dependent, alpha 1I
subunit
Mm01299033_m1
Cacybp calcyclin binding protein Mm01295897_g1
Calb1 calbindin 1 Mm00486647_m1
Calb2 calbindin 2 Mm00801461_m1
Calm1 calmodulin 1 Mm01336281_g1
Calr calreticulin Mm00482936_m1
Camk2a calcium/calmodulin-dependent
protein kinase II alpha
Mm00437967_m1
(Continued)
Table 1 | Continued
Gene symbol Gene name Assay ID
Canx calnexin Mm00500330_m1
Casq1 calsequestrin 1 Mm00486733_m1
Casq2 calsequestrin 2 Mm00486742_m1
Casr calcium-sensing receptor Mm00443375_m1
Cast calpastatin Mm00807001_m1
Cd33 CD33 antigen Mm00491152_m1
Cib1 calcium and integrin binding 1
(calmyrin)
Mm00501944_m1
Cib2 calcium and integrin binding
family member 2
Mm00498053_m1
Creb1 cAMP responsive element
binding protein 1
Mm00501607_m1
Crebbp CREB binding protein Mm01342452_m1
Dbn1 drebrin 1 Mm00517314_m1
Fbln1 fibulin 1 Mm00515700_m1
Foxo1 forkhead box O1 Mm00490672_m1
Foxo3 forkhead box O3 Mm01185722_m1
Gapdh glyceraldehyde 3-phosphate
dehydrogenase
Mm99999915_g1
Gnaq guanine nucleotide binding
protein, alpha q polypeptide
Mm00492381_m1
Gria1 glutamate receptor, ionotropic,
AMPA1 (alpha 1)
Mm00433753_m1
Gria3 glutamate receptor, ionotropic,
AMPA3 (alpha 3)
Mm00497506_m1
Grin1 glutamate receptor, ionotropic,
NMDA1 (zeta 1)
Mm00433790_m1
Grin2a glutamate receptor, ionotropic,
NMDA2A (epsilon 1)
Mm00433802_m1
Grm5 glutamate receptor,
metabotropic 5
Mm00690332_m1
Gsk3a glycogen synthase kinase 3
alpha
Mm01719731_g1
Gsk3b glycogen synthase kinase 3 beta Mm00444911_m1
Gusb glucuronidase, beta Mm01197698_m1
Hap1 huntingtin-associated protein 1 Mm00468825_m1
Hpca hippocalcin Mm00650703_m1
Htr3a 5-hydroxytryptamine (serotonin)
receptor 3A
Mm00442874_m1
Htt huntingtin Mm01213820_m1
Igf1r insulin-like growth factor 1
receptor
Mm00802831_m1
Insr insulin receptor Mm01211875_m1
Irs1 insulin receptor substrate 1 Mm01278327_m1
Irs2 insulin receptor substrate 2 Mm03038438_m1
Itpkb inositol 1,4,5-trisphosphate
3-kinase B
Mm01322781_m1
Itpr1 inositol 1,4,5-trisphosphate
receptor 1
Mm00439907_m1
Itpr2 inositol 1,4,5-triphosphate
receptor 2
Mm00444937_m1
Itpr3 inositol 1,4,5-triphosphate
receptor 3
Mm01306070_m1
(Continued)
Frontiers in Molecular Neuroscience www.frontiersin.org November 2013 | Volume 6 | Article 42 | 4
Czeredys et al. Calcium signalosome in Huntington’s disease
Table 1 | Continued
Gene symbol Gene name Assay ID
Mtor mammalian target of
rapamycin (serine/threonine
kinase)
Mm00444968_m1
Ncald neurocalcin delta Mm00774745_m1
Ncs1 neuronal calcium
sensor 1
Mm00490552_m1
Ncstn nicastrin Mm00452010_m1
Orai1 ORAI calcium
release-activated calcium
modulator 1
Mm00774349_m1
Orai2 ORAI calcium
release-activated calcium
modulator 2
Mm04214089_s1
Orai3 ORAI calcium
release-activated calcium
modulator 3
Mm01612888_m1
Pik3ca phosphatidylinositol 3-kinase,
catalytic, alpha polypeptide
Mm00435673_m1
Plcb1 phospholipase C, beta 1 Mm00479987_m1
Plcg1 phospholipase C, gamma 1 Mm01247293_m1
Ppp3ca protein phosphatase 3,
catalytic subunit, alpha
isoform
Mm01317678_m1
Psen1 presenilin 1 Mm00501184_m1
Psen2 presenilin 2 Mm00448413_m1
Psenen presenilin enhancer 2
homolog (C. elegans)
Mm00727761_s1
Pten phosphatase and tensin
homolog
Mm00477208_m1
Pvalb parvalbumin Mm00443100_m1
Rcvrn recoverin Mm00501325_m1
Rgs4 regulator of G-protein
signaling 4
Mm00501389_m1
Ryr1 ryanodine receptor 1, skeletal
muscle
Mm01175211_m1
Ryr2 ryanodine receptor 2,
cardiac
Mm00465877_m1
Ryr3 ryanodine receptor 3 Mm01328421_m1
S100a1 S100 calcium binding
protein A1
Mm01222827_m1
S100a6 S100 calcium binding protein
A6 (calcyclin)
Mm00771682_g1
Sept4 septin 4 Mm00448225_m1
Sirt1 sirtuin 1 (silent mating type
information regulation 2,
homolog) 1 (S. cerevisiae)
Mm00490758_m1
Slc25a3 solute carrier family 25
(mitochondrial carrier,
phosphate carrier)
Mm00728482_s1
Stim1 stromal interaction molecule 1 Mm00486423_m1
Stim2 stromal interaction molecule 2 Mm01223103_m1
Trpc1 transient receptor potential
cation channel, subfamily C,
member 1
Mm00441975_m1
Vsnl1 visinin-like 1 Mm01276999_m1
Table 2 | List of primers used in individual qRT-PCR for PC12 cells.
PCR
amplicon
Forward primer Reverse primer
Sept4 AGAGCATGACCCGGCTAGTA GCCGCAGCTCTTCATCTTTC
Orai1 AGAGCATGACCCGGCTAGTA TGCCCGGTGTTAGAGAATGG
Orai2 TCCATACTCCTGTCCTCGC GGCCACGTGGTTGTGTTTTT
Orai3 GGTAACTATTCCCGCTGGCT CAGCTACACCACAAACGCTG
Stim1 CTGGAGAAGAAGCTGCGTGA TTTTGGCGGCTCCTCTCATT
Stim2 TGTCTTTGCCATGGCTGGAT CTTCTGTGGGCACACTCCAT
Ryr1 GGACTACCTGTACATGGCTTAC CCTCTTCTTCACCTCCTTCTTC
Ryr2 CTCCTCACCTGGAAAGGATAAG GTCATCTCTAACCGGACCATAC
Atp2c1 TCATTCGAAAACCCCCTCGG GAAGCTCTCGCCAGAAGACA
Atp2a3 CACAGTAGCCCGGAGGAGAA TGTCACCGAGAAGCGACG
Atp2a2 TCACACAAAGACCGTGGAGG CTTCTTCAGCCGGCAATTCG
Itrp1 TCTGGAAAGCTGCTAAGCCC ATGACCGTCCCCAGCAATTT
Itpr2 GAGTCCAACCTCTTGAGCCC TCCGGTAGTTGTTGCCCTTG
Itpr3 CGTCATGAACCACGGACTGA ACTCGTCTTTGGAGGGCTTG
Trpc1 AAGGCTGCTTTCCGTTCACT TACATCTCAAGCCGCAAGCA
Trpc3 ATACCTTCACCATGCGGAGC TCACTGCTTGGAGTGCTGAG
Trpc5 AGCAGCACTCTATGTGGCAG GCACCCCGGATTTCACCTAA
Calm1a TGTCAGCAGCCAGTTTACC ACCCGTTTCCTGCACATCAT
Calm2 AAGTGTGGAGTTGTGAGCGT ACGAGTGAGTACCGGACAGA
Calm3 TGCCCGTTCTCCTGATCTCT GCGTTTGCTAGAACCGGGTA
Calm4 GTGTTCCGGGTCTTTGACCA CATTCAGCTCCTCCTCGGAC
Post GTGCTAGCTGCGATGACTCT GATGGTTTCAGGAAGGCCGA
Golli AGCATCTGAGAAGGCCAGTAA ATCTGCCTCCCCAAACACATC
Gapdh TGACTCTACCCACGGCAAGTTCAA ACGACATACTCAGCACCAGCATCA
were centrifuged at 16,000 × g for 30min at 4◦C. After mea-
suring the protein concentrations with the BC Assay Protein
Quantification Kit (Interchim), 100μg protein was loaded on
3–8% Tris-acetate gel (Invitrogen). The proteins were transferred
to a nitrocellulose membrane using the iBlot system (Invitrogen),
fixed with Ponceau S solution (Sigma) for 20 s, and then blocked
for 1 h with 3% dry non-fat milk in phosphate-buffered saline
with 0.01% Tween-20 (PBS-T) at room temperature under gentle
shaking. Themembranes were incubated overnight at 4◦C against
actin (MAB1501, 1:4000, Millipore) and huntingtin (1756-1,
1:1000, Epitomics) diluted in PBS-T that contained 3% dry non-
fat milk. After washing three times with PBS-T, the membranes
were incubated with the secondary antibody IRDye 800 goat anti-
rabbit immunoglobulin G (IgG) and IRDye 680 goat anti-mouse
IgG, (both from Licor, 926-32211 and 926-32220, respectively)
for 1 h at room temperature. The secondary antibodies were
diluted to 1:30000 in 3% dry non-fat milk in PBS-T. Afterward,
the membranes were washed three times with PBS-T and scanned
for infrared fluorescence at 680 or 800 nm using an Odyssey scan-
ner system (Licor). Brain tissue was homogenized on ice using a
glass-homogenizer (70 strokes) and cleared by centrifugation at
12,000 × g for 20min. Protein extracts (20μg) were separated
on 10% SDS-polyacrylamide gel electrophoresis (PAGE), trans-
ferred to a Protran nitrocellulose membrane (Whatman), and
blocked for 2 h at room temperature in TBS-T: 50mM Tris-HCl,
pH 7.5, 150mM NaCl, and 0.1% Tween 20 plus 5% dry non-fat
milk. Nitrocellulose sheets were then incubated at 4◦C overnight
in blocking solution with primary monoclonal antibodies against
HAP1 (611302, DB Transduction Laboratories) diluted to 1:300;
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CacyBP/SIP (ab51288, Abcam), 1:1000; Cib2 (H00010518-A01,
Abnova), 1:100; pan-cadherin (ab6528, Abcam), 1:2500; as well
as with primary polyclonal antibodies against CIB1 (11823-1-AP,
Proteintech Europe), 1:100; CALB2 (7699/3H, Swant), 1:500; and
glyceraldehyde 3-phosphate dehydrogenase (sc-25778, GAPDH)
(Santa Cruz), 1:1000. The appropriate horseradish peroxidase-
conjugated secondary antibody anti-mouse IgG (A9044) and
anti-rabbit IgG (A0545), both from Sigma, was added at a
dilution of 1:10000 for 1 h at room temperature. The peroxi-
dase was detected with enhanced chemiluminescence (Amersham
Biosciences). The intensity of the bands was measured using
an ImageQuant LAS 4000 (GE Healthcare) and Quantity One
software (Bio-Rad). Densitometry was then performed using
the intensity of GAPDH or pan-cadherin bands as an internal
standard depending on the molecular weight of the analyzed
protein.
STATISTICAL ANALYSIS
To calculate p-values for differences in gene expression levels
between the same brain regions (striatum ormotor cortex or cere-
bellum) in wildtype and transgenic mice, we applied two-tailed
paired Student’s t-test using CT values for the results obtained
with the RT-qPCR arrays (Figure 1; n = 3) or relative values for
the results obtained with individual qRT-PCRs (Table 4; n = 3).
The degree of significance vs. control is indicated by asterisks:
∗p < 0.05, ∗∗p < 0.005, ∗∗∗p < 0.0005 (ns, not significant, p >
0.05). To make the criteria for statistical significance more strin-
gent, the Bonferroni correction (p < 0.00052) was applied. This
was calculated as the p-value (0.05) divided by 96, which is the
number of studied genes (Noble, 2009).
RESULTS
DIFFERENCES IN GENE EXPRESSION BETWEEN TRANSGENIC HD MICE
(YAC128) ANDWILDTYPE MICE IN THE STRIATUM, CEREBELLUM AND
MOTOR CORTEX
To estimate the relative mRNA levels of the ensemble of genes that
encode the calciosome, custom-made RT-qPCR arrays were pre-
pared containing genes expressed in the mouse brain according to
the Allen Brain Atlas (www.brain-map.org; accessed July 2, 2013;
Table 1). We dissected the striatum from 3-month-old YAC128
mice and non-transgenic controls and analyzed the expression of
four standards, 57 calciosome genes, as well as genes implicated
in HD and Alzheimer’s disease (AD) using two technical repli-
cates. For comparison, we also performed these analyses using
preparations of the cerebellum and motor cortex.
All 96 genes present in our custom-made PCR arrays were
detected in the forebrain. In the striatum, ∼31 of the analyzed
genes exhibited a statistically significant difference (p < 0.05) in
expression between YAC128 mice and control mice (Figure 1A).
Twenty-seven genes were expressed at a higher level in HD trans-
genic mice compared with non-transgenic mice, and four genes
were expressed at a lower level. Statistically significant differences
between gene expression in YAC128 mice and control mice were
observed in the cerebellum and motor cortex. In the cerebellum,
eight genes exhibited enhanced expression inHD transgenicmice,
and in the cortex, two had enhanced expression and eight reduced
expression relative to control animals (Figures 1B,C).
FIGURE 1 | Expression of calcium signaling and homeostasis genes in
the striatum, cerebellum and motor cortex. The volcano plot arranges
genes along the dimensions of (x) mean expression fold difference
between the analyzed brain structures: (A) striatum (STR), (B) cerebellum
(CB), and (C) motor cortex (CX) in YAC128 mice and control mice (CTRL),
and (y ) p-value (Student’s t-test). A logarithmic scale is used. Points located
above the red lines represent genes whose expression was significantly
changed (p < 0.05). The results represent data based on three independent
mRNA preparations from the studied brain structures of 3-month-old mice.
EXPRESSION OF GENES POTENTIALLY IMPLICATED IN HD IN YAC128
MICE
To identify genes with potential significance in this HD ani-
mal model, we focused on genes whose expression was changed
at least 1.5-fold in the striatum; namely, Hap1 (huntingtin-
associated protein 1), Calb2 (calretinin), Aph1 (anterior pharynx
defective 1 homolog) isoforms a, b and c, Psenen (presenilin
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enhancer 2 homolog), Psen2 (presenilin 2), Cib1 (calmyrin 1),
CacyBP/SIP (calcyclin-binding protein), Calr (calreticulin), and
Cib2 (calmyrin 2).
The expression of Hap1, Calb2, and Aph1b was approximately
three-times higher in the striatum of HD mice compared to con-
trol mice.When we employed the Bonferroni correction, of the 31
genes whose mRNA levels were significantly changed in the stria-
tum in YAC128 mice, only the Aph1b gene met the criterion of
p < 0.00052.
The most prominent changes in gene expression between
3-month-old YAC128 mice and non-transgenic mice were
observed in the striatum (Figure 1A). This is consistent with the
fact that the first changes that occur in the brains of patients
suffering from HD also appear in the striatum (Vonsattel et al.,
1985). Since the clinical and pathological changes become more
apparent with age, we analyzed the same brain structure in 6-
month-old YAC128 mice and wildtype animals. Equal amounts
of cDNA obtained from the striatum in three transgenic HDmice
and three control mice were prepared, and real-time PCRwas per-
formed using our RT-qPCR array. The most significant changes
that were observed in the striatum in 3-month-old YAC128 mice
were also observed in 6-month-old HD animals. The genes whose
expression exhibited at least a 1.3-fold increase in 6-month-old
mice were compared to the list of genes that were overexpressed
in the striatum in 3-month-old mice. Eleven genes were identified
that had significantly higher expression in the striatum in mice
YAC128 of both ages (Table 3) comparing to control mice.
In addition to the genes that had higher expression in the stria-
tum in YAC128 mice, two genes were downregulated in both age
cohorts: Bace1, a gene that encodes the β-secretase component
(β-site APP cleaving enzyme 1), and Rgs4, a member of the fam-
ily of guanosine triphosphatase (GTPase)-activating proteins that
regulate Gq and Gi proteins (Huang et al., 1997). However, in con-
trast to the up to three-fold increases associated with the other
genes, the level of these two mRNAs decreased by only 10–30%
(0.7–0.9-fold).
In the group of genes presented in Table 3, onlyAph1b had p <
0.00052, as calculated using the Bonferroni correction. However,
we also identified 12 other genes that did not meet the Bonferroni
correction criterion. Nevertheless, for these genes, we observed
high relative quantification and the same extent ofmRNA changes
in the striatum in both HD mice groups compared with control
mice. We therefore chose to check some of these results at the
protein level.
VERIFICATION OF GENE EXPRESSION DATA AT THE PROTEIN LEVEL
DETERMINED BY WESTERN BLOT
Protein extracts from the striatum of 3-, 4-, and 6-month-old
YAC128 and age-matched control mice were prepared, separated
by SDS-PAGE, and incubated with primary antibodies against
HAP1, CacyBP/SIP, CALB2, CIB2, CIB1 and GAPDH or pan-
cadherin as loading controls. In six independent western blot
experiments, we observed increase in CacyBP/SIP and CIB2 pro-
teins in the striatum of YAC128 mice compared to control mice
(Figures 2B,D). In five out of six blots there was an increase in
HAP1 protein (Figure 2A) and a decrease in CIB1 (Figure 2E). In
four out of six blots we observed increase in CALB2 (Figure 2C).
This confirms that screening for changes at the mRNA level is
feasible but must be followed by verification at the protein level.
REDUCTION OF SOCE BY EXPRESSION OF MUTATED HUNTINGTIN IN
PC12 CELLS
To functionally evaluate our results at the cellular level, we
adopted a cellular model of HD; namely, inducible PC12 cells
(Apostol et al., 2003), in which an expanded HTT with 73 glu-
tamines is expressed upon treatment with the insect steroid
ponasterone A (Figure 3A). We first investigated the effects of
mutated HTT on intracellular Ca2+ homeostasis and the expres-
sion of the genes identified in the first part of the study. Cultured
PC12 cells were separated into two portions; one was treated
with ponasterone A for 48 h to induce the expression of mutated
human HTT and the other one with vehicle. For the calcium
imaging experiments, both cultures were incubated with Fura-
2AM. SOCE was examined by incubating the cells in a calcium-
free medium (0.5mM EGTA) followed by store depletion with
2μM of the SERCA pump inhibitor thapsigargin (TG). The rein-
troduction of extracellular Ca2+ evoked a robust Ca2+ influx that
corresponded to SOCE in both types of PC12 cells. However,
cells with human HTT exhibited a significant reduction in Ca2+
reentry compared with control cells (Figure 3C).
In order to check if mutant HTT affect the ER Ca2+ store
content in PC12 cells, we incubated cells either in the absence
of extracellular Ca2+ or in the presence of 2mM Ca2+. Next,
2μM TG was added to inhibit Ca2+-ATPase and the amount of
calcium ions released from ER were detected. The TG-releasable
pool was smaller under both conditions in the cells with induced
expression of HTT, but the difference did not reach statistical
significance (Figures 3D,E). PC12 cells expressing mutant HTT
exhibited significant differences in SOCE, which is in line with
our hypothesis that HD is caused or accompanied by changes in
the calciosome.
Next, we tried to verify the expression of those calciosome
components that were regulated in YAC128 mice using induced
PC12 cells. Surprisingly, we did not detect changes in Hap1,
Calb2, Aph1b, or CacyBP/SIP gene expression in this model.
We then chose genes that encode proteins known to be directly
involved in SOCE or genes that encoded proteins that regulate
SOCE activity to find a possible explanation for the reduced
SOCE in inducible huntingtin-expressing PC12 cells. As shown
in Table 4, we detected a statistically significant downregulation
of Orai calcium release-activated calcium modulator 2 (Orai2),
calmodulin 3 (Calm3), and septin 4 (Sept4). No changes in other
genes that encode proteins that directly participate in SOCE,
such as STIMs, RYRs, IP3Rs, SERCAs, and other Orais, were
detected. No changes were found in other genes that encode pro-
teins that indirectly regulate SOCE, such as TRPCs, CALMs, Golli,
Post, and TMEM66. These data suggest that different mecha-
nisms contribute to changes in calcium homeostasis in inducible
huntingtin-expressing PC12 cells and transgenic YAC128 mice.
DISCUSSION
Several studies have investigated gene expression in HD models
and HD patients using microarray analysis and discovered genes
whose expression is altered (Luthi-Carter et al., 2000, 2002a,b;
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Table 3 | Gene expression analysis in the striatum in YAC128 mice.
Gene symbol Gene name Striatum (3 months) Striatum (6 months)
Student’s t-test Relative quantification Relative quantification
Hap1 huntingtin-associated protein 1 * 3.1 1.8
Calb2 calbindin 2 (calretinin) ns 2.9 2.1
Aph1b anterior pharynx defective 1b homolog (C. elegans) *** 2.9 1.9
Psenen presenilin enhancer 2 homolog (C. elegans) * 2.3 1.5
Aph1a anterior pharynx defective 1a homolog (C. elegans) ** 2.3 1.9
Psen2 presenilin 2 * 2.0 1.6
Cib1 calcium and integrin binding 1 (calmyrin 1) ** 2.0 1.3
CacyBP/SIP calcyclin binding protein * 1.8 1.6
Aph1c anterior pharynx defective 1c homolog (C. elegans) * 1.7 1.9
Calr calreticulin * 1.5 1.6
Cib2 calcium and integrin binding family member 2 ** 1.5 1.8
Bace1 beta-site APP cleaving enzyme 1 * 0.7 0.8
Rgs4 regulator of G-protein signaling 4 * 0.8 0.9
The striatum from 3- and 6-month-old YAC128 mice was compared to age-matched control mice using custom-made TaqMan low-density PCR arrays. Only statisti-
cally significant gene expression changes are shown: *p < 0.05, **p < 0.005, ***P < 0.0005, with the exception of Calb2. Cut-offs of relative quantification (RQ) >
1.3 for upregulated genes and RQ < 0.75 for downregulated genes were applied as criteria for differential expression in transgenic mice, with the exception of Rgs4,
which did not meet the additional criterion RQ < 0.75. The results for control mice were normalized to a value of 1. The gene expression results were normalized to
GAPDH (n = 3 independent biological samples for 3-month-old YAC128 and age-matched control mice). The final concentration of cDNA for the RT-qPCR array was
1.6μg. This amount contained the combination of equal amounts of cDNA obtained either from the striatum of three 6-month-old transgenic HD mice or from three
age-matched control mice.
Table 4 | Gene expression analysis of induced and uninduced PC12
cells.
Gene
symbol
Gene name Student’s t-test Relative
quantification
Orai2 Orai calcium
release-activated
calcium
modulator 2
* 0.8
Calm3 calmodulin 3 * 0.8
Sept4 septin 4 * 0.8
PC12 cells induced by ponasterone A were compared to uninduced cells using
qRT-PCR. The gene expression results were normalized to GAPDH. Data from
uninduced PC12 cells were normalized to a value of 1. Only statistically signif-
icant gene expression changes are shown (*p < 0.05). The results represent
data based on three independent mRNA preparations.
Desplats et al., 2006; Hodges et al., 2006). We expanded these
studies to the YAC128 transgenic mice because they exhibit a
slow, long-term progression of symptoms characteristic of HD
(Slow et al., 2003), which may help identify the primary effects
of mutant HTT. We focused on genes that encode members of
calcium signalosomes (calciosome) because changes in calcium
signaling and homeostasis components have been suggested to be
early steps in the development of HD (Giacomello et al., 2011,
2013).
We found that ∼32% of the analyzed genes in the striatum
exhibited statistically significant changes in expression in YAC128
mice compared with control mice (Figure 1A). In the cerebellum
and motor cortex, the levels of expression of fewer genes dif-
fered between YAC128 mice and wild type mice (Figures 1B,C),
which is consistent with changes occurring first in the striatum
of patients suffering from HD (Vonsattel et al., 1985). In the
striatum, one gene, Aph1b, was positively regulated, even after
a Bonferroni correction (p < 0.00052) to correct for multiple
testing. Nevertheless,∼13% of genes in the striatummet the arbi-
trary criteria after cut-offs of relative quantification results (RQ
> 1.3 for upregulated genes and RQ < 0.75 for downregulated
genes) were applied (Table 3). They were characterized by the
same extent of mRNA changes in the striatum in both groups,
3- and 6-month-old HD mice, as compared with control mice.
Western blots were performed to check, if the change of specific
mRNA level affect the level of a particular protein (Figure 2).
At the top of our list, presenting the highest score for
relative quantification in the striatum in transgenic YAC128
mice compared with control mice, is the mRNA coding
for huntingtin-associated protein 1 (Table 3). Our results
revealed a three-fold increase in the expression of Hap1 in
the striatum in YAC128 mice compared with control mice.
This is consistent with data obtained using another trans-
genic mouse model, R6/2. The enrichment of several mRNAs,
including Hap1 (although not statistically significant), was
observed in neuronal nitric-oxide-synthase-positive interneurons
compared with medium spiny projection neurons (Zucker et al.,
2005).
Hap1 did not meet the criterion of the Bonferroni correc-
tion (p < 0.00052), however, an increase in HAP1 protein was
observed in brain extracts from five out of six studied YAC128
mice using western blotting (Figure 2A). In these five samples
about 1.8–2.8-fold increase at the protein level of HAP1 was
observed, except one sample, which exhibited 0.46-fold decrease
of HAP1. Also, this sample showed unusually high level of CIB2
protein as compared to other five samples (Figure 2D). HAP1
is known to play a role in signal transduction, the regulation
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FIGURE 2 | Protein expression analysis in the striatum in YAC128 mice.
Immunoblots of HAP1 (A), CacyBP/SIP (B), CALB2 (C), CIB2 (D), and CIB1
(E) in the striatum of YAC128 mice and age-matched control mice (CTRL) are
shown. First two blots show the data from 3- month-old mice, third and
fourth blots—from 4-month-old mice, and fifth and sixth blots from
6-month-old animals. 20μg of protein was loaded on the gel. HAP1
densitometry was performed using the intensity of GAPDH (A). Pan-cadherin
bands were used as an internal standard for CacyBP/SIP (B), CALB2 (C),
CIB2 (D), and CIB1 (E). The fold change of the studied proteins is shown
above the immunoblots.
of vesicular transport, gene transcription, and the regulation of
membrane receptor recycling (Wu and Zhou, 2009). It was iden-
tified as an HTT-interacting protein in yeast two-hybrid screens
(Li et al., 1995). HAP1 protein binds more tightly to HTT with
an expanded glutamine repeat than to wildtype HTT, and the
binding is enhanced by lengthening the glutamine repeat (Li
et al., 1998). A IP3R1-HAP1A-HTT ternary complex was iden-
tified in the brain that facilitates IP3R1-mediated intracellular
Ca2+ release in MSNs and is activated only by mutant HTT (Tang
et al., 2003). Interactions betweenHTT and the IP3R1 C-terminus
depend on both, the presence of HAP1 and polyglutamine expan-
sion. Mutant HTT can bind to the IP3R1 C-terminus either
directly or indirectly through HAP1. The functional effects of
mutant HTT on IP3R1-mediated Ca2+ release are attenuated in
medium spiny striatal neurons inHap1 knockout mice compared
with MSNs in wildtype mice (Tang et al., 2004).
Members of calcium signalosomes, which were significantly
upregulated in the striatum in YAC128 mice, were Calb2,
CacyBP/SIP, Cib1, Cib2, and Carl. An increase at the protein level
in samples from six animals was observed for CacyBP/SIP protein
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FIGURE 3 | Huntingtin expression in PC12 cells reduces SOCE.
Immunoblots of huntingtin (A) and actin (B) in induced (+) and
uninduced (−) PC12 cells are shown. Ratiometric Fura-2 analysis of
uninduced and induced PC12 cells was performed on a BD Pathway
high-content imaging system. (C) SOCE measurements began in a
buffer supplemented with 0.5mM EGTA, which was then replaced by a
buffer with 0.5mM EGTA and 2μM thapsigargin (TG). After 2.5min, the
readdition of 2mM Ca2+ to the extracellular media resulted in Ca2+
influx. The traces show only Ca2+ readdition after store depletion.
F340/F380 values beginning just before the readdition of Ca2+ were
normalized to the same values (1). The ER calcium stores were depleted
by the addition of 2μM TG in the presence (D) or absence (E) of
extracellular Ca2+. F340/F380 values beginning just before the addition of
TG were normalized to the same values (1) (C–E, left panels). The data
from different experiments were averaged (C–E, right panels). Summary
data present the maximum (peak) of the F340/F380 ratio after the
addition of Ca2+ or TG are expressed as the mean ± SD of the data
shown in the left panels. ∗p < 0.05; ns, not significant (p > 0.05).
Averaged traces from (C) 52 individually measured wells that contained
a total of ∼2,000 cells per trace, (D) 52 individually measured wells
that contained a total of ∼2,000 cells per trace, and (E) 16 individually
measured wells that contained a total of ∼500 cells per trace.
and CIB2 (Figures 2B,D). CALB2 protein increased in four sam-
ples (1.5, 2.5, 2.25, and 1.3-fold), and two were characterized
by a slightly lower expression of CALB2 in the striatum (0.79
and 0.7-fold). Taking into account the possible fluctuations in
neuronal calcium, this result can be explained by the fact that
some antibodies to calcium-binding proteins, including CALB2,
preferentially recognize particular calcium-induced protein con-
formations (Winsky and Kuznicki, 1996). CALB2 is a member of
the EF-hand family of calcium-binding proteins, which interacts
with wildtype HTT but preferentially with mutant HTT (Dong
et al., 2012). In neuronal cell models of HD, the overexpression
of CALB2 reduced mutant HTT-induced cytotoxicity, whereas
knockdown of Calb2 enhanced mutant HTT-induced neuronal
cell death (Dong et al., 2012). It was suggested that CALB2 may
protect only medium-sized neurons against neurodegeneration
in HD (Cicchetti and Parent, 1996). However, neurodegenerative
processes that play a role in HD led to a decrease in the density of
CALB2 in large striatal interneurons, without causing their death
(Massouh et al., 2008). An increase in the expression of Calb2
in the striatum in YAC128 mice may indicate the presence of
a defense mechanism against mutant HTT-induced cytotoxicity.
However, high-throughput analysis did not identify an increase
in Calb2 in HD patients (Hodges et al., 2006). In contrast, a
decrease in the expression of Calb1, which encodes another 6
EF-hands calcium binding protein, calbindin, was found in post-
mortem brain samples from the caudate of HD patients (Hodges
et al., 2006). This is consistent with the substantial loss of neu-
rons in the neostriatum that contain calbindin, suggesting that a
failure of calcium buffering may contribute to cell death in HD
(Seto-Ohshima et al., 1988).
The expression of CacyBP/SIP was also significantly upregu-
lated in the striatum in YAC128 mice relative to control mice.
This result was confirmed by western blotting, which showed an
increase in a 30-kDa calcyclin (S100A6)-binding protein in all six
studied samples. The CacyBP/SIP protein may play a role in the
organization of microtubules and in calcium-dependent ubiquiti-
nation of target proteins (Filipek and Kuznicki, 1998; Matsuzawa
and Reed, 2001; Filipek et al., 2002, 2008; Jurewicz et al., 2013).
The statistically significant upregulation of Cib1 mRNA in
YAC128mice is consistent with a seven-fold increase in this gene’s
mRNA in microarray studies of the striatum in HD patients
(Hodges et al., 2006). However, at the protein level this cannot
be confirmed (Figure 2E), since we observed downregulation of
CIB1 in samples from the striatum of five animals (0.15, 0.7, 0.85,
0.78, and 0.5-fold) and an increase in one (1.6-fold). We detected
a statistically significant increase in Cib2 mRNA and this result
was confirmed by six independent western blotting experiments,
showing an increase in CIB2 protein (Figure 2D). CIBs are EF-
hand Ca2+ binding proteins identified in the brain (Bernstein
et al., 2005; Blazejczyk et al., 2009). CIB1 has been implicated
in neurodegenerative processes in AD, in which it was shown
to interact with presenilin 2, but not presenilin 1 (Blazejczyk
et al., 2006), but the role of CIBs in HD has not yet been
confirmed.
Another gene that was significantly upregulated on the mRNA
level in the striatum of YAC128 mice compared with control mice
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was Calr, however, the microarray studies did not detect upregu-
lation of Calr in brain structures in HD patients (Hodges et al.,
2006). Calreticulin is a multifunctional protein that acts as a tran-
scription factor in the nucleus or binds Ca2+ in the ER (Michalak
et al., 2009).
We detected statistically significant changes in the gene expres-
sion of Psen2 mRNA in YAC128 mice and other components
of γ-secretase complex, such as Psenen and Aph1 isoforms.
Considering that only the Aph1b gene met the criterion for
Bonferroni correction, we speculate that this gene may by
involved in the pathogenesis of HD. APH1 encoded by the
Aph1 gene is required for proteolytic activity and binds to the
γ-secretase complex (Lee et al., 2004). Presenilins and Psenen are
involved in the cleavage of the Notch receptor and APP process-
ing (Francis et al., 2002; Goutte et al., 2002; Luo et al., 2003).
Moreover, PSENs participate also in the modulation of Ca2+ sig-
naling in the ER (Leissring et al., 2000; Supnet and Bezprozvanny,
2011). Thus, one can associate the altered gene expression of
γ-secretase components with abnormal proteolytic activity in HD
(Tarlac and Storey, 2003). It was suggested that HTT-interacting
protein HIP1 (huntingtin-interacting protein 1) may provide a
functional link between non-canonical Notch signaling-mediated
neurogenesis through a deltex-dependent pathway (Moores et al.,
2008).
In our experiments, most of the genes exhibited upregulation,
in contrast to the results obtained from Affymetrix oligonu-
cleotide array studies in HD R6/2 mice (Desplats et al., 2006),
in which a decrease in the expression level of a majority of the
genes was observed. R6/2 mice express exon 1 of human HD gene
carrying 116 CAG repeats and exhibit a more progressive neuro-
logical phenotype (Mangiarini et al., 1996). However, comparing
the results of high-throughput studies with our present study,
which focused on a small group of genes, we identified some sim-
ilarities. We and Desplats et al. (2006) detected a decrease in the
expression of the Rgs4 gene that encodes a protein involved in the
regulation of G-protein signaling. Similarly, statistically signifi-
cant downregulation of Rgs4was found in the striatum andmotor
cortex in HD patients using Affymetrix GeneChip microarrays
(Hodges et al., 2006). The RGS4 protein inhibits Gq, which, in
turn, attenuates intracellular calcium signaling via phospholipase
C (Berman et al., 1996). This is in line with results suggesting a
cytosolic andmitochondrial Ca2+ overload inHD (Bezprozvanny
and Hayden, 2004).
Cellular models of HD are another tool to detect the early,
direct effects of mutant HTT without the influence of other sec-
ondary processes in advanced stages of the disease. We used PC12
cells with inducible expression of mutant HTT. Others have char-
acterized this model in regard to HTT aggregates: 1 day after
induction, only a few cells that expressed mutant HTT con-
tained aggregates, whereas 5 days after induction, nearly all of
the cells contained visible aggregates (Cong et al., 2005). We ana-
lyzed the cells 2 days after induction of HTT expression, which
exhibited overexpression of expanded HTT protein (Figure 3A)
and unchanged level of actin protein (Figure 3B) as found by
immunoblotting. We observed a statistically significant reduction
of calcium influx during SOCE, but not calcium content in the
ER, in inducible huntingtin-expressing PC12 cells compared with
control uninduced cells. This indicates that despite the likely asso-
ciation of mutant HTT with the ER (Rockabrand et al., 2007),
the Ca2+ content of PC12 cells is not changed. Reduced activ-
ity of the SOCE in induced PC12 cells might be explained by
our finding that Orai2, Sept4 and Calm3 are downregulated. The
Orai calcium channel is activated during SOCE (Frischauf et al.,
2008). Septin 4 has been shown to facilitate interactions between
STIM1 andOrai1 proteins (Sharma et al., 2013).Microarray stud-
ies of the caudate fromHDpatients detected a seven-fold decrease
in the expression of Calm3 (Hodges et al., 2006). In induced
PC12 cells, a decrease in the expression of another isoform of
calmodulin, Calm1, has been described (van Roon-Mom et al.,
2008). Calmodulins are multifunctional intermediate messenger
proteins that transduce calcium signals by binding calcium ions
and thenmodifying their interactions with various target proteins
(Chin and Means, 2000). A previous study found that HTT inter-
acts with calmodulin and that the expansion of polyglutamine
altered this interaction (Bao et al., 1996).
In contrast to the observed decrease in SOCE in PC12 cells
(this work) in cultured MSNs from YAC128 mice, an increase in
calcium influx during SOCE was reported by Wu and coworkers.
They demonstrated a key role of TRPC1 channels in supporting
the SOC pathway in HD neurons (Wu et al., 2011). However, we
did not find any differences in Trpc1 gene expression in induced
PC12 cells. The differences in SOCE dysregulation observed
between the YAC128 mouse model by Wu et al. and our obser-
vation in PC12 cells may result from the length of mutated HTT,
which can selectively affect gene expression. Alternatively, the dif-
ference could be due to the length of time mutated HTT was
expressed. MSNs from YAC128 mice used by Wu et al. were cul-
tured from 10–14 days, while PC12 cells were analyzed 2 days after
HTT induction.
Although inducible PC12 cells and transgenic YAC128 mice
show different changes in calcium influx during SOCE, each of
these models has characteristic features of HD, such as the depo-
sition of HTT aggregates mainly in the nuclei of inducible PC12
cells (van Roon-Mom et al., 2008) and nuclei of MSNs in the
striatum in YAC128 mice (Van Raamsdonk et al., 2007). In both
models, some similarities with the results obtained from samples
from HD patients as well as other HD transgenic and cellular
models were observed. In our experiments, the expression of
Rgs4, Hap1, Cib1, and Calm3 changed in the same direction as
the changes reported by other studies.
This work presents for the first time convincing data demon-
strating an increased expression of huntingtin-associated protein
1 in the striatum of HD mouse model at the mRNA and pro-
tein level. Our data showing upregulation of HAP1 are in line
with those of Wu et al. (2011) when the observations of Tang
et al. are taken into account (Tang et al., 2003, 2004). They found
that mutant Htt via the interaction with HAP1 can activate IP3R1
in vivo. Thus, activation of SOCE reported by Wu et al. (2011)
could be explained by the increased release of Ca2+ from ER due
to the facilitated opening of the IP3R1. Since the dysregulation
of neuronal Ca2+ represents an early event in the pathogene-
sis of models of HD (Zeron et al., 2002; Tang et al., 2003), the
HAP1 protein might be considered as a potential therapeutic
target in HD.
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